Sun Pharmaceutical Industries has secured investment-grade ratings from Moody's and S&P for its proposed $11.75 billion ...

Novartis' cholesterol drug pelacarsen fails to reduce heart attack and stroke risk in late-stage study, impacting investor ...

Biocon has signed a significant 10-year contract to supply pertuzumab, a breast cancer drug, in Brazil, emphasizing its ...

Novo Nordisk announces the termination of two heart drug trials for ziltivekimab, casting doubt on its diversification ...

In a significant ruling, the Supreme Court of India has dismissed Sanofi's petition against a CBI complaint involving alleged ...

Roivant's experimental drug mosliciguat has demonstrated significant efficacy in treating pulmonary hypertension linked to ...

New Zealand's health authorities have granted approval for the use of MDMA in treating severe PTSD, making it only the second ...

Novartis India has announced the acquisition of Pfizer's hypertension drug Minipress for ₹1250 crore, aiming to enhance its ...

HRV Pharma, based in Hyderabad, is set to invest ₹150 crore to enhance its peptide manufacturing capabilities and develop ...

Novo Nordisk reports a significant reduction in obesity rates among children aged 6 to under 12 treated with semaglutide in a ...

New Delhi: More than 60% of the 8,500 registered small and medium pharmaceutical units in India may be forced to shut shop by the end of this month for failing to comply with the guidelines on good ...

Fosun Pharma reduces its stake in Gland Pharma, selling 4.5% through block deals on BSE, attracting several major investors ...